Research Article
Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer
Table 1
Clinical and tumor characteristics of patients.
| | Histology | | Male/female | Ages (years) | Size (cm3) | SUVmax-PET/CT | SUVmax-PET/MRI | ADCmax (×10−3 mm2/S) |
| | Malignant | 30 | 24/6 | 34-76 | | | | | | Tubular adenocarcinoma (h) | 0 | | | | | | | | Tubular adenocarcinoma (m) | 9 | 8/1 | 34-64 | | | | | | Tubular adenocarcinoma (l) | 12 | 10/2 | 37-76 | | | | | | Signet ring cell carcinoma | 2 | 0/2 | 47, 62 | NA, 6.00 | 3.31, 1.82 | 1.51, 1.55 | 1.70, 1.89 | | Adenocarcinoma/signet ring cell carcinoma/mucinous adenocarcinoma | 5 | 5/0 | 48-64 | | | | | | Adenocarcinoma/neuroendocrine carcinoma | 2 | 1/1 | 64, 73 | 84, 160 | 24.70, 14.10 | 28.50, 14.00 | 0.97
0.70 |
|
|
